14 research outputs found
Initiation of antiretroviral therapy in early presentation contributes to normalization of CD8 T cell counts rather than late presentations in HIV infection
No full text
Rapid virologic response in chronic hepatitis C genotype 1: Evaluation of pretreatment factors in patients
No full textBackground and study aims: Rapid virologic response (RVR) is defined as undetectable hepatitis C virus (HCV) RNA in serum after 4 weeks of treatment for chronic hepatitis C (CHC). Paritaprevir/ritonavir/ombi tasvir (PRO) and/or dasabuvir (D), with or without ribavirin [PRO (D) ribavirin], which are direct-acting antivirals (DAAs), is the currently approved treatment regimen for CHC genotype 1; this regimen can also be used in patients with end-stage renal failure (ESRF). In this study, we aimed to evaluate the effect of pretreatment factors on RVR in patients treated with PRO (D) +/- ribavirin
The Rapid Virological Response in Chronic Hepatitis C Genotype 1 and 4: Evaluation of Pre-treatment Factors in Patient
No full text
İzmir Tepecik Eğitim ve Araştırma Hastanesi Enfeksiyon Hastalıkları Kliniğinde İzlenen Kronik İnaktif Hepatit B Tanılı Hastalarda Spontan Hbsag klirensi ve Anti-Hbs Oluşumu Seroprevelansı
No full text
